Relationship between ragweed pollen counts and delivery of anti allergic medication

E. Van Ganse, R. Harf, C. Dechamp, F. Clouet, A. Jacquier, D. Flasquel, L. Ellul, M. Calleja, L. Laforest (Lyon, Pierre Benite, St Priest, Montpellier, France)

Source: Annual Congress 2002 - Epidemiology of asthma, rhinitis and allergy
Session: Epidemiology of asthma, rhinitis and allergy
Session type: Thematic Poster Session
Number: 812
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Van Ganse, R. Harf, C. Dechamp, F. Clouet, A. Jacquier, D. Flasquel, L. Ellul, M. Calleja, L. Laforest (Lyon, Pierre Benite, St Priest, Montpellier, France). Relationship between ragweed pollen counts and delivery of anti allergic medication. Eur Respir J 2002; 20: Suppl. 38, 812

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The relation between pollen count and outbreak of seasonal allergic rhinitis for korean pollen allergy scale
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009


Prevalence of sensitization to grass pollen purified allergens in patients allergic to grass pollen
Source: Eur Respir J 2002; 20: Suppl. 38, 507s
Year: 2002

Pollen sensitization in allergic asthma patients in correlation to pollen specter
Source: Eur Respir J 2005; 26: Suppl. 49, 131s
Year: 2005

IgE specific for recombinant grass pollen allergens in allergic respiratory disease
Source: Eur Respir J 2005; 26: Suppl. 49, 380s
Year: 2005

Specific immunotherapy with high dose grass allergen tablets was safe in grass pollen induced asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 134s
Year: 2005

Inflammatory markers in induced sputum of patients with allergic rhinitis in relation to exposure to pollen allergens
Source: Eur Respir J 2006; 28: Suppl. 50, 444s
Year: 2006

Clinical efficiency of sublingual and subcutaneous allergenspecific immunotherapy with household dust mite allergen in patients with persistent allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 438s
Year: 2006

Sublingual immunotherapy is an established therapy for house dust mite sensitive allergic rhinitis and/or asthma
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007


Relation of month of birth and hypersensitivity to grass pollen in asthmatic children
Source: Eur Respir J 2002; 20: Suppl. 38, 115s
Year: 2002

Estimation of prevalence of grass pollen sensitization among patients with seasonal allergic rhinitis in Armenia
Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Year: 2018


Association between Th2 biomarker levels and efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Humoral markers of inflammation in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens
Source: Eur Respir J 2004; 24: Suppl. 48, 595s
Year: 2004

Evaluation of specific IgE to recombinant pollen allergens in asthmatic patients with specific IgE to phleum pratense
Source: Eur Respir J 2001; 18: Suppl. 33, 434s
Year: 2001

Behaviour of indexes of platelet activity and active fibrinolysis in plasma from patients with seasonal allergic rhinitis and concomitant asthma during pollen season
Source: Eur Respir J 2006; 28: Suppl. 50, 237s
Year: 2006

Grass pollen allergen induces asthma symptoms in a murine model of acute allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 587s
Year: 2005

Effects of 3-yr immunotherapy with standardised extracts of house dust mite in allergic asthmatic subjects receiving appropriate drug treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 107s
Year: 2002

House dust mite sublingual immunotherapy reduces type 2 biomarkers in allergic asthma
Source: Virtual Congress 2020 – Management of allergy, asthma and COPD
Year: 2020


Circulating platelets activity in patients sensitised to house dust mite suffering from persistent allergic rhinitis with or without asthma symptoms
Source: Eur Respir J 2005; 26: Suppl. 49, 590s
Year: 2005

Effect of allergen-specific immunotherapy on platelet secretory activity in patients with house-dust mite allergy
Source: Eur Respir J 2007; 30: Suppl. 51, 369s
Year: 2007

Diagnostic utility of serum periostin for house dust mite sublingual immunotherapy response in allergic rhinitis
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021